Future of nanotherapeutics: Targeting the cellular sub-organelles.
暂无分享,去创建一个
Xing-Jie Liang | Xing-Jie Liang | Xiao-wei Ma | N. Gong | Lin Zhong | Jiadong Sun | Xiaowei Ma | Ningqiang Gong | Lin Zhong | Jiadong Sun | Xing-jie Liang | X. Liang | Xiaowei Ma
[1] M. Lahiri,et al. Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells. , 2015, ACS applied materials & interfaces.
[2] Yasuo Yoshioka,et al. A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[3] V. Torchilin,et al. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. , 2008, Nano letters.
[4] Cuichen Wu,et al. A Cell-Targeted, Size-Photocontrollable, Nuclear-Uptake Nanodrug Delivery System for Drug-Resistant Cancer Therapy , 2014, Nano letters.
[5] Dar-Bin Shieh,et al. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. , 2008, Biomaterials.
[6] Y. Yoshioka,et al. Induction of Endoplasmic Reticulum–Endosome Fusion for Antigen Cross-Presentation Induced by Poly (γ-Glutamic Acid) Nanoparticles , 2011, The Journal of Immunology.
[7] D. Wirtz,et al. Efficient active transport of gene nanocarriers to the cell nucleus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] Jinchao Zhang,et al. Ultrasmall Gold Nanoparticles as Carriers for Nucleus-Based Gene Therapy Due to Size-Dependent Nuclear Entry , 2014, ACS nano.
[9] D A Jans,et al. Signals mediating nuclear targeting and their regulation: Application in drug delivery , 1998, Medicinal research reviews.
[10] I. Komuro,et al. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. , 2010, Circulation research.
[11] Y. Liu,et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. , 2011, Nano letters.
[12] G. Pastorin,et al. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin. , 2014, Biomaterials.
[13] Ge Lin,et al. Rapid endosomal escape of prickly nanodiamonds: implications for gene delivery , 2015, Scientific Reports.
[14] M. Akashi,et al. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells. , 2008, Vaccine.
[15] M. Garcia-Parajo,et al. pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins. , 2011, Biomacromolecules.
[16] R. Dwek,et al. Uptake and trafficking of liposomes to the endoplasmic reticulum , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] S. Muro,et al. Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery. , 2015, Molecular pharmaceutics.
[18] M. El-Sayed,et al. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. , 2010, Journal of the American Chemical Society.
[19] S. Dhar,et al. The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate , 2014, Chemical science.
[20] L. Rajendran,et al. Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.
[21] Ya-ju Chang,et al. Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy. , 2015, Biomaterials.
[22] F. Scaglia,et al. Mitochondrial cytopathies. , 2016, Cell calcium.
[23] Huangxian Ju,et al. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer. , 2013, Journal of the American Chemical Society.
[24] Anthony H. Futerman,et al. The cell biology of lysosomal storage disorders , 2004, Nature Reviews Molecular Cell Biology.
[25] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] S. Kelley,et al. Targeted delivery of doxorubicin to mitochondria. , 2013, ACS chemical biology.
[27] S. Cohen,et al. ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation. , 2013, Genes & development.
[28] S. Dhar,et al. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics , 2012, Proceedings of the National Academy of Sciences.
[29] Y. Shinohara,et al. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. , 2001, Advanced drug delivery reviews.
[30] Fang Zeng,et al. Dual-targeting nanosystem for enhancing photodynamic therapy efficiency. , 2015, ACS applied materials & interfaces.
[31] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[32] Virander S. Chauhan,et al. Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene delivery , 2013, Journal of Nanobiotechnology.
[33] H. Harashima,et al. Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter. , 2013, Mitochondrion.
[34] V. Muzykantov,et al. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] D. Stepensky,et al. Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro. , 2011, Molecular pharmaceutics.
[36] Erik C. Dreaden,et al. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. , 2012, Accounts of chemical research.
[37] F. Rodríguez,et al. Targeting plasmid‐encoded proteins to the antigen presentation pathways , 2004, Immunological reviews.
[38] L. Du,et al. Targeted surface-functionalized gold nanoclusters for mitochondrial imaging. , 2014, Biosensors & bioelectronics.
[39] Qianjun He,et al. MSN‐Mediated Sequential Vascular‐to‐Cell Nuclear‐Targeted Drug Delivery for Efficient Tumor Regression , 2014, Advanced materials.
[40] Da Ma,et al. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. , 2014, Nanoscale.
[41] Vladimir P Torchilin,et al. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. , 2006, Annual review of biomedical engineering.
[42] Yan-jun Zhong,et al. Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy , 2012, International journal of oncology.
[43] Erkki Ruoslahti,et al. Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.
[44] Yu Chen,et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.
[45] V. Lukyanenko. Permeabilization of cell membrane for delivery of nano-objects to cellular sub-domains. , 2013, Methods in molecular biology.
[46] H. Wootz,et al. ER stress and neurodegenerative diseases , 2006, Cell Death and Differentiation.
[47] R. Iacobazzi,et al. In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[48] Guankui Wang,et al. KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[49] D. Maysinger,et al. Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria. , 2012, Biomacromolecules.
[50] Samir Mitragotri,et al. Multifunctional nanoparticles for drug delivery and molecular imaging. , 2013, Annual review of biomedical engineering.
[51] R. Hill,et al. High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[52] Yuyang Sun,et al. Functional role of TRP channels in modulating ER stress and Autophagy. , 2016, Cell calcium.
[53] D. Stojanovski,et al. Import of Nuclear‐Encoded Proteins into Mitochondria , 2003, Experimental physiology.
[54] Elena Aznar,et al. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides". , 2010, ACS nano.
[55] W. Lederer,et al. Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles. , 2007, Biophysical journal.
[56] Masato Yasuhara,et al. Quantum Dots Targeted to the Assigned Organelle in Living Cells , 2004, Microbiology and immunology.
[57] Betty Y. S. Kim,et al. Current concepts: Nanomedicine , 2010 .
[58] Silvia Muro,et al. Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[59] W. Mark Saltzman,et al. Therapeutic siRNA: Principles, Challenges, and Strategies , 2012, The Yale journal of biology and medicine.
[60] L. C. Moore,et al. Nuclear envelope permeability , 1975, Nature.
[61] Meng Zheng,et al. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride. , 2012, Biomaterials.
[62] V. Muzykantov,et al. Polymer nanocarriers protecting active enzyme cargo against proteolysis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[63] Paul C. Wang,et al. Single-walled carbon nanotubes alter cytochrome c electron transfer and modulate mitochondrial function. , 2012, ACS nano.
[64] Youqing Shen,et al. Nuclear drug delivery for cancer chemotherapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[65] H. Harashima,et al. Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process. , 2012, Methods in enzymology.
[66] Teri W Odom,et al. Direct observation of nanoparticle-cancer cell nucleus interactions. , 2012, ACS nano.
[67] Tim Leshuk,et al. Emerging nanomaterials for targeting subcellular organelles , 2011 .
[68] F. Lim,et al. General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination , 2013, Current gene therapy.
[69] H. Harashima,et al. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier. , 2013, Mitochondrion.
[70] Peng Huang,et al. ROS stress in cancer cells and therapeutic implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[71] P. Couvreur,et al. Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. , 2012, ACS nano.
[72] Sangeeta N. Bhatia,et al. Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking , 2004 .
[73] S. Weinberg,et al. Targeting mitochondria metabolism for cancer therapy. , 2015, Nature chemical biology.
[74] Michal Juhas,et al. Gold nanoparticles induce nuclear damage in breast cancer cells, which is further amplified by hyperthermia , 2014, Cellular and Molecular Life Sciences.
[75] S. Kelley,et al. Mitochondria‐Penetrating Peptides: Sequence Effects and Model Cargo Transport , 2009, Chembiochem : a European journal of chemical biology.
[76] J. Nunnari,et al. Mitochondrial form and function , 2014, Nature.
[77] R. Dwek,et al. Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells , 2010, Proceedings of the National Academy of Sciences.
[78] R. Dwek,et al. Liposome-Mediated Delivery of Iminosugars Enhances Efficacy against Dengue Virus In Vivo , 2012, Antimicrobial Agents and Chemotherapy.
[79] Y. Zhan,et al. Targeted charge-reversal nanoparticles for nuclear drug delivery. , 2007, Angewandte Chemie.
[80] Omid C Farokhzad,et al. Insight into nanoparticle cellular uptake and intracellular targeting. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[81] V. Torchilin,et al. Intracellular Targets for DNA Delivery: Nuclei and Mitochondria , 2002, Somatic cell and molecular genetics.
[82] Timothy J. Nelson,et al. Nuclear Transport: Target for Therapy , 2007, Clinical pharmacology and therapeutics.
[83] Xian‐Zheng Zhang,et al. Dual-pH Sensitive Charge-Reversal Polypeptide Micelles for Tumor-Triggered Targeting Uptake and Nuclear Drug Delivery. , 2015, Small.
[84] Dai Fukumura,et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.
[85] E. Ruoslahti,et al. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[86] Katarina Kågedal,et al. The lysosome: from waste bag to potential therapeutic target. , 2013, Journal of molecular cell biology.
[87] M. Prato,et al. Peptide-based carbon nanotubes for mitochondrial targeting. , 2013, Nanoscale.
[88] I. Tabas,et al. Role of endoplasmic reticulum stress in metabolic disease and other disorders. , 2012, Annual review of medicine.
[89] Takenori Yamamoto,et al. MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. , 2008, Biochimica et biophysica acta.
[90] Kirsten Sandvig,et al. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .
[91] V. Weissig,et al. Mitochondrial pharmaceutics. , 2004, Mitochondrion.
[92] H. Padh,et al. Organelle targeting: third level of drug targeting , 2013, Drug design, development and therapy.
[93] S. Kelley,et al. Mitochondria-penetrating peptides. , 2008, Chemistry & biology.
[94] J. Feijen,et al. Lysosomally cleavable peptide-containing polymersomes modified with anti-EGFR antibody for systemic cancer chemotherapy. , 2011, Biomaterials.
[95] Jing Wang,et al. Pegylated phospholipid micelles induce endoplasmic reticulum-dependent apoptosis of cancer cells but not normal cells. , 2012, ACS nano.
[96] K. Raghu,et al. A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy. , 2014, Organic & biomolecular chemistry.
[97] O. Inanami,et al. Radiosensitization of tumor cells through endoplasmic reticulum stress induced by PEGylated nanogel containing gold nanoparticles. , 2014, Cancer letters.
[98] Silvia Muro,et al. Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[99] S. Amigorena,et al. Intracellular mechanisms of antigen cross presentation in dendritic cells. , 2010, Current opinion in immunology.
[100] Liangping Zhou,et al. Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes. , 2012, Biomaterials.
[101] Yaping Li,et al. Large‐Pore Ultrasmall Mesoporous Organosilica Nanoparticles: Micelle/Precursor Co‐templating Assembly and Nuclear‐Targeted Gene Delivery , 2015, Advanced materials.
[102] R. Kaufman,et al. Endoplasmic reticulum stress and type 2 diabetes. , 2012, Annual review of biochemistry.